# PCSA (Processa Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> Processa Pharmaceuticals, Inc. reported $182.0M in total assets and a net loss of $193.2M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/PCSA
- Markdown: https://convexityos.com/fundamentals/PCSA.md
- SEC CIK: 0001533743
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:09 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001533743&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$193.5M | Operating profit |
| Net Income | FY 2025 | -$193.2M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$64.95 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $180.2M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | $0 | $0 | -- | -- | -- | -- | $5.0K |
| **Gross Profit** | -- | -- | -- | -- | -- | -- | -- | -- | -- | $5.0K |
| Research & Development | $7.81M | $7.27M | $5.80M | $11.49M | $6.88M | $3.17M | $2.32M | $3.09M | $964K | $1.54M |
| Selling, General & Admin | -- | -- | -- | -- | -- | -- | -- | $1.44M | $838K | $70K |
| Total Operating Expenses | -- | -- | -- | -- | -- | -- | -- | -- | $1.80M | $1.92M |
| **Operating Income** | -$13.99M | -$12.05M | -$11.46M | -$27.53M | -$12.13M | -$15.14M | -$3.94M | -$4.52M | -$1.80M | -$1.92M |
| **EBITDA** | -$13.99M | -$12.05M | -$11.46M | -- | -$11.34M | -$14.33M | -$3.13M | -$3.89M | -$1.80M | -$1.92M |
| Interest Income | $109K | $201K | $336K | $101K | $12K | $3.2K | $12K | $18K | $5.2K | $4.5K |
| Interest Expense | -- | -- | -- | -- | $362 | $281K | $37K | $161K | $59K | $245K |
| Income Before Tax | -$13.56M | -$11.85M | -$11.12M | -$27.42M | -$11.96M | -$15.41M | -$3.96M | -$4.67M | -$1.86M | -$337K |
| Income Tax Expense | -- | -- | -- | -- | -$531K | -$1.00M | -$603K | -$903K | $259K | -- |
| **Net Income** | -$13.56M | -$11.85M | -$11.12M | -$27.42M | -$11.43M | -$14.41M | -$3.36M | -$3.77M | -$1.86M | -$1.92M |
| Basic EPS | -$10.36 | -$96.78 | -$212.00 | -$851.25 | -$375.00 | -$1,270.00 | -$350.00 | -$355.00 | -$30.00 | -$35.00 |
| **Diluted EPS** | -$10.36 | -$96.78 | -$212.00 | -$851.25 | -$375.00 | -$1,270.00 | -$350.00 | -$355.00 | -$30.00 | -$35.00 |
| Basic Shares Outstanding | 1.3M | 122.4K | 52.5K | 32.2K | 30.6K | 15.0K | 11.1K | 10.7K | 65.2K | 58.6K |
| Diluted Shares Outstanding | 1.3M | 122.4K | 52.5K | 32.2K | 30.6K | 15.0K | 11.1K | 10.7K | 65.2K | 58.6K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $1.81M | $650K | $1.81M | $2.11M | $1.66M | $2.45M | $1.59M | $1.71M |
| **Operating Income** | -$184.1M | -$2.34M | -$3.33M | -$3.70M | -$3.49M | -$3.95M | -$2.85M | -$2.73M |
| **EBITDA** | -$184.1M | -$2.34M | -$3.33M | -$3.70M | -$3.49M | -$3.95M | -$2.85M | -$2.73M |
| Interest Income | -- | -- | $14K | -- | -- | -- | $13K | -- |
| Income Before Tax | -- | -- | -$3.38M | -- | -- | -- | -$2.83M | -- |
| **Net Income** | -$183.2M | -$3.27M | -$3.38M | -$3.36M | -$3.44M | -$3.93M | -$2.83M | -$2.73M |
| Basic EPS | -$61.58 | -$1.19 | -$1.29 | -- | -$1.81 | -$6.26 | -$7.58 | -- |
| **Diluted EPS** | -$61.58 | -$1.19 | -$1.29 | -- | -$1.81 | -$6.26 | -$7.58 | -- |
| Basic Shares Outstanding | 3.0M | 2.8M | 2.6M | -- | 1.9M | 628.8K | 374.0K | -- |
| Diluted Shares Outstanding | 3.0M | 2.8M | 2.6M | -- | 1.9M | 628.8K | 374.0K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $5.54M | $1.19M | $4.71M | $6.50M | $16.50M | $15.42M | $692K | $1.74M | $2.85M | $1.07M |
| **Cash & Short-Term Investments** | $5.54M | $1.19M | $4.71M | $6.50M | $16.50M | $15.42M | $692K | $1.74M | $2.85M | $1.07M |
| **Total Current Assets** | $5.67M | $1.88M | $5.63M | $8.39M | $18.33M | $16.20M | $1.01M | $2.02M | $2.95M | $2.34M |
| Property, Plant & Equipment, Net | $4.0K | $5.0K | $2.6K | -- | -- | $484 | $8.9K | $17K | $26K | $22K |
| Intangible Assets | -- | -- | -- | -- | $8.06M | $8.85M | $9.64M | $10.44M | -- | -- |
| Other Non-Current Assets | -- | -- | $5.5K | $5.5K | $5.5K | $9.01M | $9.87M | $10.44M | $5.5K | $5.5K |
| **Total Non-Current Assets** | $2.14M | $1.27M | $154K | $233K | $8.14M | $9.01M | $9.88M | $10.46M | $31K | $28K |
| **Total Assets** | $7.81M | $3.23M | $5.79M | $8.62M | $26.46M | $25.21M | $10.88M | $12.48M | $2.98M | $2.36M |
| Accounts Payable | $1.06M | $881K | $312K | $328K | $219K | $321K | $76K | $292K | $51K | $15K |
| Short-Term Debt | -- | -- | -- | -- | -- | -- | -- | $230K | $2.45M | -- |
| Other Current Liabilities | -- | -- | $39 | $51 | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $2.24M | $1.53M | $731K | $999K | $971K | $1.22M | $1.19M | $646K | $2.60M | $98K |
| **Total Non-Current Liabilities** | $0 | $487 | $67K | $151K | $7.4K | $1.05M | $1.68M | $2.13M | $10.0K | $0 |
| **Total Liabilities** | $2.24M | $1.53M | $797K | $1.15M | $978K | $2.27M | $2.87M | $2.78M | $2.61M | $98K |
| **Total Debt (incl. Leases)** | -- | $74K | $151K | $229K | $78K | $166K | $225K | $230K | $2.45M | -- |
| Common Stock | $257 | $15 | $129 | $80 | $1.6K | $1.4K | $549 | $552 | $3.5K | $3.2K |
| Retained Earnings | -$100.8M | -$87.22M | -$75.37M | -$64.25M | -$36.82M | -$25.40M | -$10.98M | -$7.62M | -$3.86M | -$2.00M |
| **Total Stockholders' Equity** | $5.58M | $1.70M | $4.99M | $7.47M | $25.49M | $22.94M | $8.01M | $9.70M | $373K | -$2.27M |
| Total Equity | $5.58M | $1.70M | $4.99M | $7.47M | $25.49M | $22.94M | $8.01M | $9.70M | $373K | -$2.27M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $180.2M | $196K | $1.69M | $5.54M | $6.31M | $6.94M | $2.90M | $1.19M |
| **Cash & Short-Term Investments** | $180.2M | $196K | $1.69M | $5.54M | $6.31M | $6.94M | $2.90M | $1.19M |
| **Total Current Assets** | $182.0M | $2.07M | $1.94M | $5.67M | $6.59M | $7.15M | $3.76M | $1.88M |
| Property, Plant & Equipment, Net | $3.0K | $3.2K | $3.5K | $4.0K | $4.1K | -- | -- | $5.0K |
| **Total Non-Current Assets** | $3.0K | $3.2K | $2.58M | $2.14M | $998K | $1.03M | $1.05M | $1.27M |
| **Total Assets** | $182.0M | $2.07M | $4.52M | $7.81M | $7.58M | $8.18M | $4.81M | $3.23M |
| Accounts Payable | $1.19M | $1.66M | $840K | $1.06M | $727K | $786K | $553K | $881K |
| **Total Current Liabilities** | $1.86M | $2.39M | $1.98M | $2.24M | $1.75M | $2.07M | $1.28M | $1.53M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $487 |
| **Total Liabilities** | $1.86M | $2.39M | $1.98M | $2.24M | $1.75M | $2.07M | $1.28M | $1.53M |
| **Total Debt (incl. Leases)** | -- | -- | -- | -- | -- | $26K | $50K | $74K |
| Common Stock | -- | $279 | $269 | $257 | $5.3K | $4.0K | $527 | $15 |
| Retained Earnings | -$290.6M | -$107.4M | -$104.2M | -$100.8M | -$97.42M | -$93.99M | -$90.05M | -$87.22M |
| Accumulated Other Comp. Income | -$20K | -- | -- | -- | -- | -- | -- | -- |
| **Total Stockholders' Equity** | -$181.4M | -$318K | $2.54M | $5.58M | $5.83M | $6.11M | $3.53M | $1.70M |
| Total Equity | -$181.4M | -$318K | $2.54M | $5.58M | $5.83M | $6.11M | $3.53M | $1.70M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$13.56M | -$11.85M | -$11.12M | -$27.42M | -$11.43M | -$14.41M | -$3.36M | -$3.77M | -$1.86M | -$1.92M |
| Depreciation & Amortization | $1.2K | $782 | $222 | -- | $791K | $804K | $804K | $630K | $1.9K | $1.4K |
| Stock-Based Compensation | $858K | $630K | $1.06M | $8.83M | $3.41M | $2.73M | $510K | $74K | -- | $6.7K |
| Change in Payables | $176K | $569K | -$16K | $109K | -$102K | $245K | -$216K | $241K | $10.0K | $3.7K |
| **Operating Cash Flow** | -$11.39M | -$11.25M | -$8.06M | -$9.61M | -$8.72M | -$3.14M | -$2.75M | -$3.71M | -$1.65M | -$2.16M |
| Capital Expenditure | -- | -$3.2K | -$2.8K | -- | -- | -- | -- | -- | -$21K | -$24K |
| **Free Cash Flow** | -- | -$11.25M | -$8.07M | -- | -- | -- | -- | -- | -$1.68M | -$2.18M |
| **Investing Cash Flow** | -$850K | -$3.2K | -$2.8K | -- | -- | -- | -- | -$22K | $1.00M | -$1.04M |
| Common Stock Issued | $16.60M | $7.76M | $6.32M | $6.40M | $10.05M | $17.10M | -- | $2.87M | -- | $4.27M |
| Share Repurchases | -- | -- | -- | -$300K | -- | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $16.58M | $7.73M | $6.27M | -$389K | $9.80M | $17.87M | $1.70M | $2.62M | $2.43M | $4.27M |
| **Net Change in Cash** | $4.35M | -$3.51M | -$1.80M | -$9.99M | $1.08M | $14.72M | -$1.05M | -$1.11M | $1.78M | $1.07M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$183.2M | -$3.27M | -$3.38M | -$3.36M | -$3.44M | -$3.93M | -$2.83M | -$2.73M |
| Depreciation & Amortization | $398 | $301 | $301 | $204 | $398 | $301 | $301 | $301 |
| Stock-Based Compensation | $846K | $92K | $96K | $124K | $303K | $203K | $228K | $155K |
| Change in Payables | -$2.95M | $819K | -$216K | $330K | -$59K | $233K | -$328K | $169K |
| **Operating Cash Flow** | -$5.18M | -$2.00M | -$3.59M | -$2.90M | -$3.48M | -$2.27M | -$2.73M | -$2.25M |
| **Investing Cash Flow** | -$1.90M | $186K | -$500K | -- | -- | -- | -- | -- |
| Common Stock Issued | -$270 | $315K | $245K | $2.98M | $2.86M | $6.32M | $4.44M | $549K |
| **Financing Cash Flow** | $187.1M | $315K | $245K | $2.98M | $2.86M | $6.31M | $4.44M | $548K |
| **Net Change in Cash** | $180.0M | -$1.49M | -$3.85M | -$771K | -$628K | $4.04M | $1.71M | -$1.70M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -- | -- | -- | -- | -- | -- | 100.0% |
| **Operating Margin** | -- | -- | -- | -- | -- | -- | -- | -- | -- | -38430.4% |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -- | -- | -- | -- | -38341.3% |
| Return on Equity (ROE) | -243.2% | -698.7% | -222.9% | -367.1% | -44.8% | -62.8% | -41.9% | -38.8% | -497.5% | -- |
| Return on Assets (ROA) | -173.6% | -367.0% | -192.2% | -318.2% | -43.2% | -57.2% | -30.9% | -30.2% | -62.2% | -81.1% |
| Current Ratio | 2.54x | 1.23x | 7.71x | 8.40x | 18.87x | 13.27x | 0.85x | 3.13x | 1.14x | 23.92x |
| Quick Ratio | 2.48x | 0.78x | 6.44x | 6.51x | 16.99x | 12.63x | 0.58x | 2.70x | 1.10x | 10.97x |
| Debt to Equity | -- | 0.04x | 0.03x | 0.03x | 0.00x | 0.01x | 0.03x | 0.02x | 6.56x | -- |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -- | -- | -- | -- | -- | -95.6% |
| 5Y Revenue / Share Growth | -- | -- | -- | -- | -100.0% | -- | -- | -- | -- | -- |
| 10Y Revenue / Share Growth | -- | -- | -- | -100.0% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -- | -555.2% | -243.2% | -221.7% | -210.9% | -338.9% | -698.7% |
| Return on Assets (ROA) | -106.1% | -649.4% | -312.0% | -173.6% | -170.5% | -157.4% | -248.6% | -367.0% |
| Current Ratio | 97.70x | 0.87x | 0.98x | 2.54x | 3.76x | 3.45x | 2.93x | 1.23x |
| Quick Ratio | 96.73x | 0.08x | 0.85x | 2.48x | 3.60x | 3.34x | 2.26x | 0.78x |
| Debt to Equity | -- | -- | -- | -- | -- | 0.00x | 0.01x | 0.04x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
